Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

By sjmartinez • March 7, 2023

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial. Emerg Microbes Infect. 2023 Mar 6:2187247. doi: 10.1080/22221751.2023.2187247. Epub ahead of print. PMID: 36872899.

Tags: clofazimine, Infectious Diseases, Parabolic Response Surface, Publications, pulmonary tuberculosis, Randomized clinical trial, Short-course treatment

Design and evaluation of next-generation HIV genotyping for detection of resistance mutations to 28 antiretroviral drugs across five major classes including lenacapavir

Park SY, Takayama C, Ryu J, Sattah M, Badii Z, Kim JW, Shafer RW, Gorbach PM, Lee HY. Design and evaluation of next-generation HIV genotyping[...]

The Search for the Golden Egg: Applied Large Language Models to Detect Patients With Potential Exposure to Avian Influenza

Shenoy ES, Branch-Elliman W, Wiens J. The Search for the Golden Egg: Applied Large Language Models to Detect Patients With Potential Exposure to Avian Influenza.[...]

Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial

Turner NA, Hamasaki T, Doernberg SB, Lodise TP, King HA, Ghazaryan V, Cosgrove SE, Jenkins TC, Liu C, Sharma S, Zaharoff S, Wahid L, Renard[...]